Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Cash from Operations (Quarterly): -143.71M for Sept. 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -143.71M |
| June 30, 2023 | -131.40M |
| March 31, 2023 | -190.18M |
| December 31, 2022 | -128.80M |
| September 30, 2022 | -137.81M |
| June 30, 2022 | -143.49M |
| March 31, 2022 | -160.47M |
| December 31, 2021 | -137.98M |
| September 30, 2021 | -47.03M |
| June 30, 2021 | -93.37M |
| March 31, 2021 | -110.42M |
| December 31, 2020 | -76.42M |
| September 30, 2020 | -76.76M |
| June 30, 2020 | -59.34M |
| March 31, 2020 | -59.00M |
| December 31, 2019 | -41.90M |
| September 30, 2019 | -32.87M |
| June 30, 2019 | -38.47M |
| March 31, 2019 | -34.48M |
| December 31, 2018 | -20.80M |
| September 30, 2018 | -20.17M |
| June 30, 2018 | -21.18M |
| March 31, 2018 | -7.948M |
| December 31, 2017 | -13.77M |
| September 30, 2017 | -15.09M |
| Date | Value |
|---|---|
| June 30, 2017 | -17.62M |
| March 31, 2017 | -18.23M |
| December 31, 2016 | -16.12M |
| September 30, 2016 | -18.30M |
| June 30, 2016 | -16.64M |
| March 31, 2016 | -16.95M |
| December 31, 2015 | -16.03M |
| September 30, 2015 | -15.87M |
| June 30, 2015 | -9.039M |
| March 31, 2015 | -9.775M |
| December 31, 2014 | -8.587M |
| September 30, 2014 | -9.617M |
| June 30, 2014 | -5.746M |
| March 31, 2014 | -8.798M |
| December 31, 2013 | -7.712M |
| September 30, 2013 | -5.195M |
| June 30, 2013 | -9.208M |
| March 31, 2013 | -7.34M |
| December 31, 2012 | -5.188M |
| September 30, 2012 | -4.183M |
| June 30, 2012 | -2.818M |
| March 31, 2012 | -4.461M |
| December 31, 2011 | -3.630M |
| September 30, 2011 | -2.374M |
| June 30, 2011 | -2.316M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-190.18M
Minimum
Mar 2023
-32.87M
Maximum
Sep 2019
-100.52M
Average
-101.89M
Median
Cash from Operations (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 2.834B |
| Karuna Therapeutics Inc (DELISTED) | -111.06M |
| Puma Biotechnology Inc | 11.25M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -62.19M |
| Cash from Financing (Quarterly) | 334.70M |
| Free Cash Flow | -595.93M |
| Free Cash Flow Per Share (Quarterly) | -2.212 |
| Free Cash Flow to Equity (Quarterly) | -143.75M |
| Free Cash Flow to Firm (Quarterly) | -143.75M |